Shire Allowed Access To Confidential Info In Adderall Row
Amerigen Pharmaceuticals Inc. has to let Shire LLC look through its confidential information, namely its abbreviated new drug application, to figure out if it infringed Shire's patent for Adderall XR, a...To view the full article, register now.
Already a subscriber? Click here to view full article